Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries.
暂无分享,去创建一个
E. Antman | R. Giugliano | E. Braunwald | A. Kirtane | S. Murphy | C. Gibson | D. Frisch | Graham Gardner
[1] R. Gibbons,et al. Impairment of myocardial perfusion in both culprit and nonculprit arteries in acute myocardial infarction: a LIMIT AMI substudy. , 2003, The American journal of cardiology.
[2] A. L'Abbate,et al. Coronary microcirculatory vasoconstriction during ischemia in patients with unstable angina. , 2000, Journal of the American College of Cardiology.
[3] F. Crea,et al. Widespread coronary inflammation in unstable angina. , 2003, The New England journal of medicine.
[4] H. Heidbuchel,et al. Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction: Results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial , 2002, Circulation.
[5] L. Deckelbaum,et al. Global impairment of coronary blood flow in the setting of acute coronary syndromes (a RESTORE substudy)1 , 2000 .
[6] R. Califf,et al. Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial. , 2003, Journal of the American College of Cardiology.
[7] E. Braunwald,et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. , 1999, Circulation.
[8] E. Antman,et al. Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction. , 1999, Journal of the American College of Cardiology.
[9] T Sandor,et al. Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials. , 1992, The American journal of cardiology.
[10] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.
[11] W. Ganz,et al. The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.
[12] H. Katus,et al. Impaired coronary flow and left ventricular dysfunction after mechanical recanalization in acute myocardial infarction: role of neurohumoral activation? , 2002, Basic Research in Cardiology.
[13] J. Dodge,et al. Thrombolysis in Myocardial Infarction frame count in saphenous vein grafts. , 1998, American heart journal.
[14] C. Di Mario,et al. Effects of selective alpha1- and alpha2-adrenergic blockade on coronary flow reserve after coronary stenting. , 2002, Circulation.
[15] H. White,et al. Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected Thrombolysis in Myocardial Infarction (TIMI) frame count and stenosis severity. , 1998, The American journal of cardiology.
[16] E. Braunwald,et al. Relationship of the TIMI Myocardial Perfusion Grades, Flow Grades, Frame Count, and Percutaneous Coronary Intervention to Long-Term Outcomes After Thrombolytic Administration in Acute Myocardial Infarction , 2002, Circulation.
[17] A. Distante,et al. α-Adrenergic Blockade Improves Recovery of Myocardial Perfusion and Function After Coronary Stenting in Patients With Acute Myocardial Infarction , 1999 .
[18] E. Braunwald,et al. TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.